Similar articles

• Guanfacine extended-release for attention-deficit/hyperactivity disorder (ADHD).

  Sallee FR, Eaton K. Sallee FR, et al. Expert Opin Pharmacother. 2010 Oct;11(15):2549-56. doi: 10.1517/14656566.2010.517523. Expert Opin Pharmacother. 2010. PMID: 20831361 Review.
• The role of alpha2-adrenergic agonists in attention-deficit/hyperactivity disorder.

  Sallee FR. Sallee FR. Postgrad Med. 2010 Sep;122(5):78-87. doi: 10.3810/pgm.2010.09.2204. Postgrad Med. 2010. PMID: 20861591 Review.
• Guanfacine extended-release (intuniv) for ADHD.

  [No authors listed] [No authors listed] Med Lett Drugs Ther. 2010 Oct 18;52(1349):82-3. Med Lett Drugs Ther. 2010. PMID: 21045757 No abstract available.
• Clonidine extended-release in attention-deficit hyperactivity disorder: profile report.

  Croxtall JD. Croxtall JD. CNS Drugs. 2012 Mar 1;26(3):277-9. doi: 10.2165/11208310-000000000-00000. CNS Drugs. 2012. PMID: 22248146 No abstract available.
• A review of the rationale and clinical utilization of α2-adrenoceptor agonists for the treatment of attention-deficit/hyperactivity and related disorders.

  Sallee F, Connor DF, Newcorn JH. Sallee F, et al. J Child Adolesc Psychopharmacol. 2013 Jun;23(5):308-19. doi: 10.1089/cap.2013.0028. J Child Adolesc Psychopharmacol. 2013. PMID: 23782125 Review.